Source: Annual Congress 2012 - Respiratory infectious diseases Grand Round: an interactive session
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
P. Corris (Newcastle-Upon-Tyne, United Kingdom). Pseudomonas before and after lung transplantation: to treat or not to treat?. Annual Congress 2012 - Respiratory infectious diseases Grand Round: an interactive session

Member's Comments

No comment yet.

Related content which might interest you: Interstitial lung diseases and transplantation - how to choose the best candidate? Source: Virtual Congress 2021 – Optimising outcomes of lung transplantation: how to move forward? Year: 2021 IPC-related pleural infection vs. colonisation - to treat or not to treat? Source: International Congress 2019 – Pleural infection and complicated pneumonia Year: 2019 Lung transplantation: the ideal treatment for diffuse disease? Source: Annual Congress 2006 - Up to date management of bronchiectasis Year: 2006 Pseudomonas aeruginosa eradication after lung transplantation: is it the tip of the iceberg? Source: Eur Respir J, 58 (1) 2004380; 10.1183/13993003.04380-2020 Year: 2021 The murine orthotopic single lung transplantation model for chronic rejection: work in progress? Source: International Congress 2018 – Lung transplant science: from primary graft to chronic allograft dysfunction Year: 2018 Granulomatous reaction in a patient with lung cancer: should we treat it? Source: Breathe, 14 (3) e94; 10.1183/20734735.014617 Year: 2018 Who to treat/who not to treat: hypoxic lung disease Source: School Course 2012 - Pulmonary hypertension and pulmonary vascular disease Year: 2012 Rapid decline in lung disease other than COPD: when should lung transplantation be considered? Source: Annual Congress 2007 - Rapid decline in lung function and its consequences Year: 2007 Infectious complications after lung transplantation Source: ISSN=1025-448x, ISBN=1-904097-29-4, page=193 Year: 2003 Who should treat lung cancer patients and where should they be treated? Source: Annual Congress 2009 - Fitness for radical therapy in lung cancer patients Year: 2009 Pseudomonas aeruginosa and chronic lung allograft dysfunction: does evading an iceberg prevent the ship from sinking? Source: Eur Respir J, 58 (1) 2100041; 10.1183/13993003.00041-2021 Year: 2021 New antifibrotic drugs: will interstitial diseases patients still need lung transplantation? Source: Virtual Congress 2020 – Lung transplantation in the era of new drugs Year: 2020 Does colonization with pseudomonas affects the prevalence of bronchiolitis obliterans syndrome after lung transplantation? Source: Annual Congress 2006 - Dealing with chronic allograft dysfunction: mission impossible? Year: 2006 Lung transplantation in rare lung diseases: the problem of chronic lung allograft dysfunction (CLAD) Source: International Congress 2018 – Rare lung diseases Year: 2018 How to manage pseudomonas infections: chronic and acute Source: CME Online 2019 Year: 2019 Which is the best source of mesenchymal cells to treat acute lung injury? Source: Annual Congress 2011 - Mechanisms of acute lung injury and mesenchymal cell treatment Year: 2011 Selection of emphysema patients for lung transplantation today Source: Annual Congress 2004 - Lung transplantation: new insights in advanced lung disease and new drug developments - do they impact on selection criteria? Year: 2004 Poor performance status patient in advanced lung cancer: to treat or not to treat? Source: Annual Congress 2008 - MP13 - Poor performance status patient in advanced lung cancer: to treat or not to treat? Year: 2008